Estimating Public Economic Gains from Early Breast Cancer and Curative Treatment: A Case Study in Human Epidermal Growth Factor Receptor (HER-2) Positive Targeted Therapies

Abstract Introduction Cancer diagnosis influences the choices that patients make regarding current and future labor market activity. These choices have implications for governments based on resulting changes in taxes paid and benefits received. In this analysis we explore how human growth receptor 2...

Descrición completa

Detalles Bibliográficos

Principais autores:	Svenn Alexander Kommandantvold, Nikos Kotsopoulos, Isabel Monteiro, Ana Ladeiras, Andrew Hogan, Felipe Barboza Magalhães de Araujo, Mark P. Connolly
Formato:	Artigo
Idioma:	Inglês
Publicado:	Adis, Springer Healthcare 2024-02-01
Series:	Oncology and Therapy
Assuntos:	Fiscal analysis Cost–benefit analysis HER2-positive breast cancer Life course modeling Cancer survival
Acceso en liña:	https://doi.org/10.1007/s40487-024-00264-9
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!